CVE-2026-108798

CVE-2026-108798 is a high-severity vulnerability with a CVSS 3.x base score of 7.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-320.

Key facts

Description

A vulnerability was found in ZKTeco BioTime 9.5.6 Build 20260130.3206. This issue affects some unknown processing. The manipulation results in use of hard-coded cryptographic key . The attack may be launched remotely. Upgrading to version 9.5.6 Build 3623 is capable of addressing this issue. It is suggested to upgrade the affected component.

Frequently asked questions

What is CVE-2026-108798?
A vulnerability was found in ZKTeco BioTime 9.5.6 Build 20260130.3206. This issue affects some unknown processing. The manipulation results in use of hard-coded cryptographic key . The attack may be launched remotely. Upgrading to version 9.5.6 Build 3623 is capable of addressing this issue. It is suggested to upgrade the affected component.
How severe is CVE-2026-108798?
CVE-2026-108798 has a CVSS 3.x base score of 7.3, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2026-108798 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2026-108798?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-108798 published?
CVE-2026-108798 was published on 2026-10-12 and last updated on 2026-10-16.

References

Other CWE-320 vulnerabilities

Browse all CWE-320 vulnerabilities →